MTRY Stock: Monterey Bio Acquisition Corporation Stock Price, Analysis & Insights
Get live MTRY stock price $11.14, comprehensive Monterey Bio Acquisition Corporation stock analysis, charts, news, and expert forecast. Real-time MTRY stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with ...
Company Information
- CEO
- Murat Omur
- Sector
- Financial Services
- Industry
- Shell Companies
- Employees
- N/A
Contact Information
- Website
- https://www.montereybio.com
- Address
- 17 State Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Lower volatility stock (Beta: 0.00) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Monterey Bio Acquisition Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Monterey Bio Acquisition Corporation
- ⚠Investors should consider how Monterey Bio Acquisition Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
48.30M
P/E Ratio (TTM)
-85.69
Beta
0.00
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MTRY with peer companies:
- Price
- $5.77
- Market cap
- 46.40M
- Price
- $0.96
- Market cap
- 68.07M
- Price
- $2.29
- Market cap
- 7.35M
- Price
- $1.75
- Market cap
- 23.06M
- Price
- $4.74
- Market cap
- 48.91M
- Price
- $9.88
- Market cap
- 48.60M
- Price
- $11.70
- Market cap
- 48.40M
- Price
- $0.80
- Market cap
- 44.17M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.